Banco Santander, S.A. Press Releases

Get SAN Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading SAN now
Exchange: NYSE
Industry: Finance
Community Rating:
View:    SAN After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

Cesar Alierta and Emilio Botin launch online education platform MiriadaX, the largest in the world in Spanish and Portuguese
7/27/2014 12:30:00 PM - PR Newswire

Rio de Janeiro, world capital of higher education as it hosts the 3rd Universia International Meeting of university presidents
7/25/2014 3:18:00 PM - PR Newswire

Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States
7/22/2014 8:45:00 AM - PR Newswire

Santander Holdings USA Declares Quarterly Dividend On Preferred Stock
7/15/2014 3:02:00 PM - PR Newswire

Grupo Financiero Santander Mexico Will Report 2Q14 Results Before Market Open on July 31, 2014
7/14/2014 12:53:00 PM - PR Newswire

Santander Named 2014 Best Bank In Western Europe, Spain, Mexico And Argentina By Euromoney Magazine
7/11/2014 2:21:00 PM - PR Newswire

First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia
7/10/2014 7:07:00 PM - GlobeNewswire

Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
7/9/2014 5:09:00 PM - GlobeNewswire

Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
7/9/2014 5:00:00 PM - PR Newswire

FDA Accepts Sanofi's New Drug Application for Basal Insulin Toujeo®
7/8/2014 8:01:00 AM - PR Newswire

CureVac Signs an Exclusive License Agreement with Sanofi Pasteur to Develop and Commercialize an mRNA-based Prophylactic Vaccine
7/1/2014 9:00:00 AM - PR Newswire

Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis
6/30/2014 8:00:00 AM - Business Wire

Pre-market Banking Picks -- Research on Banco Santander, Royal Bank of Scotland, Itau Unibanco Holding, and Banco Santander Brasil
6/19/2014 8:10:00 AM - PR Newswire

Sanofi Reports Positive Phase 3 Results for Toujeo(R)
6/14/2014 1:09:00 PM - GlobeNewswire

Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering than Liraglutide when Both were Added to Insulin Glargine
6/14/2014 1:02:00 PM - PR Newswire

Sanofi Reports Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL)
6/14/2014 1:02:00 PM - PR Newswire

Patients Continuing On Sanofi's Lantus® Had Lower Blood Sugar Levels Than Those who Switched to Insulin Detemir
6/14/2014 1:02:00 PM - PR Newswire

Sanofi and Medtronic to Form Strategic Alliance in Diabetes to Improve Patient Experience and Outcomes
6/14/2014 10:12:00 AM - GlobeNewswire

Sanofi and Regeneron Announce New, Detailed Data from Positive Sarilumab Phase 3 Rheumatoid Arthritis Trial at EULAR
6/12/2014 1:00:00 AM - PR Newswire

Santander Signs First Agreement With Ocean County College
6/11/2014 1:26:00 PM - PR Newswire

Pele, Global Santander Soccer Ambassador, Says US Team Could Be A Surprise And That Brazil Is Ready For The World Cup
6/10/2014 6:15:00 PM - PR Newswire

Santander and Massachusetts School Building Authority Recognize Winners of 8th Annual "My Ideal School" Contest
6/5/2014 3:51:00 PM - PR Newswire

Genzyme’s Lemtrada Resubmission Accepted for Review by FDA
5/30/2014 2:15:00 AM - Business Wire

Genzyme Recognizes Sixth Annual World MS Day
5/28/2014 8:00:00 AM - Business Wire

Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC
5/28/2014 7:00:00 AM - PR Newswire